Our data support our hypothesis that variation in CCR5 genetics and function contributes to a modified inflammatory response, which could explain the relatively benign course of sarcoidosis disease in patients with Löfgren’s syndrome. The gene discussed is CCR5; the disease is Löfgren’s syndrome.